A series of studies indicated that genetic alterations in the BRCA2, PALB2, and ATM genes are associated with prostate cancer risk in men that have a strong family history of prostate cancer and also increases their risk of an aggressive form of the disease.
- Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer
- Targeted Versus Systematic Prostate Biopsy
- Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead
- Radiation Therapy After Artificial Urinary Sphincter Insertion Ups Urethral Atrophy Risk
- Prognosis Good With Negative Prostate Cancer Biopsy in Active Surveillance